David Ross Smith is CFO & VP at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). They have made 38 open-market trades across 1 company since 2017, most recently 2026-07-20.
CIK 0001650274
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 38 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRL | SELL | 2022-03-03 | 2022-03-04 | $282.53 | $5.1M | -3.6% | +2.2% | -12.7% |
| CRL | SELL | 2021-08-09 | 2021-08-10 | $407.62 | $1.2M | +3.1% | +7.5% | -9.2% |
| CRL | SELL | 2021-05-04 | 2021-05-06 | $340.01 | $2.2M | -5.3% | +0.8% | +23.4% |
| CRL | SELL | 2021-04-22 | 2021-04-26 | $330.00 | $1.3M | +0.1% | -3.6% | +16.9% |
| CRL | SELL | 2021-04-15 | 2021-04-16 | $320.00 | $640K | +4.0% | +0.2% | +18.7% |
| CRL | SELL | 2021-03-01 | 2021-03-02 | $290.12 | $2.5M | +0.3% | +2.9% | +16.4% |
| CRL | SELL | 2021-02-19 | 2021-02-23 | $290.53 | $4.6M | -3.0% | -0.2% | +17.3% |
| CRL | SELL | 2021-01-04 | 2021-01-05 | $248.72 | $2.4M | +9.7% | +8.2% | +19.3% |
| CRL | SELL | 2020-08-07 | 2020-08-10 | $216.54 | $1.4M | -1.9% | -4.1% | +8.4% |
| CRL | SELL | 2020-05-07 | 2020-05-08 | $150.00 | $283K | +11.5% | +17.3% | +38.1% |
| CRL | SELL | 2020-02-26 | 2020-02-27 | $162.26 | $1.4M | -3.9% | -15.2% | +13.9% |
| CRL | SELL | 2020-02-24 | 2020-02-25 | $166.72 | $2.7M | -4.6% | -20.0% | +5.4% |
| CRL | SELL | 2020-02-13 | 2020-02-13 | $170.29 | $766K | -6.8% | -39.4% | -6.9% |
| CRL | SELL | 2019-08-12 | 2019-08-13 | $130.36 | $163K | -2.6% | +2.6% | +2.8% |
| CRL | SELL | 2019-02-27 | 2019-03-01 | $141.07 | $304K | -1.8% | +1.0% | -12.8% |
| CRL | SELL | 2019-02-26 | 2019-02-28 | $139.65 | $161K | -1.8% | +1.7% | -12.2% |
| CRL | SELL | 2019-02-26 | 2019-02-28 | $139.76 | $566K | -1.8% | +1.7% | -12.2% |
| CRL | SELL | 2019-02-26 | 2019-02-28 | $141.51 | $225K | -1.8% | +1.7% | -12.2% |
| CRL | SELL | 2019-02-25 | 2019-02-26 | $145.43 | $582K | -1.5% | +2.4% | -8.8% |
| CRL | SELL | 2019-02-25 | 2019-02-26 | $144.55 | $609K | -1.5% | +2.4% | -8.8% |
| CRL | SELL | 2018-11-12 | 2018-11-14 | $134.49 | $251K | +1.4% | -2.3% | +1.1% |
| CRL | SELL | 2018-08-13 | 2018-08-14 | $120.08 | $154K | +1.6% | +9.5% | +11.8% |
| CRL | SELL | 2018-05-01 | 2018-05-03 | $104.23 | $98K | -0.4% | +4.2% | +19.3% |
| CRL | SELL | 2018-02-28 | 2018-03-02 | $108.43 | $11K | +6.0% | -3.0% | +1.2% |
| CRL | SELL | 2018-02-28 | 2018-03-02 | $107.91 | $594K | +6.0% | -3.0% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.